COVID-19 Funded Research
The NIH Common Fund received $30 Million from the Coronavirus Aid, Relief, and Economic Security (CARES) Act, 2020 to prevent, prepare for, and respond to coronavirus, domestically or internationally. The Office of Strategic Coordination (OSC), which manages the Common Fund is using these funds to stimulate innovative research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the disease it causes, Coronavirus Disease 2019 (COVID-19). OSC issued immediate funding opportunities in Fiscal Year 2020 for active Common Fund researchers to conduct SARS-CoV-2 and COVID-19 research. Awards issued through these funding opportunities are listed below.
Emergency Competitive Revisions for Research on SARS-COV-2 and COVID-19
The Office of Strategic Coordination (OSC), issued a Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-RM-20-015) to stimulate innovative research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the disease it causes, Coronavirus Disease 2019 (COVID-19).
OSC issued emergency competitive revisions to Common Fund grants and cooperative agreements to support innovative research on COVID-19 or SARS-CoV-2 in areas of research including behavioral/social science, health disparities, and novel therapeutics, that fit within the mission of an emergency response to provide critical expertise, resources or activities. A list of funded projects is available below. Learn more about the awardees and their funded research.
2021 NIH Director's Transformative Research Emergency COVID-19 Awards (RFA-RM-20-020)
Due to the public health emergency, the Transformative Research Award and Early Independence Award issued additional funding opportunities for COVID-19-related research on the prevention of, preparation for, or response to coronavirus SARS-CoV-2 using funds provided through the CARES Act.
|PI Name||Institution Name||Title|
|DEB, ARJUN (contact); ARUMUGASWAMI, VAITHILINGARAJA ; GRAEBER, THOMAS G; PELLEGRINI, MATTEO
|UNIVERSITY OF CALIFORNIA LOS ANGELES
|Metabolic and Epigenetic Reprogramming of Vital Organs in SARS-CoV-2 Induced Systemic Toxicity|
|Development of a Handheld Rapid Air Sensing System to Monitor and Quantify SARS-CoV-2 in Aerosols in Real-Time|
|RAY, ANIMESH (contact); HERNANDEZ, JENIFFER BERTHA
|KECK GRADUATE INST OF APPLIED LIFE SCIS
|Rapid Response for Pandemics: Single Cell Sequencing and Deep Learning to Predict Antibody Sequences Against an Emerging Antigen|
|WEINBERGER, LEOR S (contact); RODICK, ROBERT
|Autonomously Deploying, Co-Evolving SARS-CoV-2 Antiviral: A New Paradigm for Pandemic Prevention|
|YAKOUB, ABRAAM M (contact); LAZARTIGUES, ERIC D; TSENG, CHIEN-TE K
|UNIVERSITY OF NORTH DAKOTA
|SARS-CoV-2 Tropism in the Brain and Its Relationship to COVID-19 Pathogenesis|
This page last reviewed on October 5, 2022